Emerging Therapies and Hope: Diffuse Large B-cell Lymphoma

Yasmin Karimi, MD Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma. Tune in as we chat with Dr. Yasmin Karimi from the University of Michigan about the latest breakthroughs in treatment, including combination therapies, CAR T-cell therapy and bispecific antibodies. Discover how these innovations are offering new hope and pathways to cures for patients. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode:  Diffuse large B-cell lymphoma CAR T-cell Therapy Bispecific Antibodies Diffuse Large B-Cell Lymphoma: Effective Practices for Meaningful Care Conversations in a Changing Landscape You and Your Doctor: Actively Participating in Your Care: A Toolkit For Those Living With Or Caring For Someone With Diffuse Large B-Cell Lymphoma (DLBCL) Additional LLS Support Resources:  Information Specialists  Free Nutrition Consultations Financial support Free telephone/web patient programs  Free booklets  Clinical Trial Support Center Young Adult Resources Online chats  Support groups  Caregiver support  Caregiver Workbook Advocacy and Public Policy Survivorship Workbook LLS Community Mental Health Resources Support for this episode provided by Genmab US, Inc. The post Emerging Therapies and Hope: Diffuse Large B-cell Lymphoma first appeared on The Bloodline with Blood Cancer United Podcast.